Michael Quante

Freiburg, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 137 publications

Spatial immune profiling complements genomic sequencing in biliary tract cancer: hypothesis-generating use cases.

Spatial immune profiling complements genomic sequencing in biliary tract cancer: hypothesis-generating use cases.

Journal: ESMO gastrointestinal oncology

Published: April 06, 2026

Correction to: Systematic Evaluation of Clinical, Nutritional, and Fecal Microbial Factors for Their Association With Colorectal Polyps.

Correction to: Systematic Evaluation of Clinical, Nutritional, and Fecal Microbial Factors for Their Association With Colorectal Polyps.

Journal: Clinical and translational gastroenterology

Published: April 01, 2026

Correction: Maurer et al. Gut Microbial Disruption in Critically Ill Patients with COVID-19-Associated Pulmonary Aspergillosis. J. Fungi 2022, 8, 1265.

Correction: Maurer et al. Gut Microbial Disruption in Critically Ill Patients with COVID-19-Associated Pulmonary Aspergillosis. J. Fungi 2022, 8, 1265.

Journal: Journal of fungi (Basel, Switzerland)

Published: March 06, 2026

Early kinetics of CA19-9 and CEA after 5-FU-based chemotherapy for gastrointestinal cancers.

Early kinetics of CA19-9 and CEA after 5-FU-based chemotherapy for gastrointestinal cancers.

Journal: Discover oncology

Published: March 05, 2026

First-in-human EphA2-targeting PET imaging with the bicyclic radiotracer [68Ga]Ga-BCY18469 in pancreatic cancer patients: biodistribution, dosimetry and initial findings.

First-in-human EphA2-targeting PET imaging with the bicyclic radiotracer [68Ga]Ga-BCY18469 in pancreatic cancer patients: biodistribution, dosimetry and initial findings.

Journal: European journal of nuclear medicine and molecular imaging

Published: February 17, 2026

Clinical Impact of Molecular Tumor Board Inclusion on Treatment Outcomes in Neuroendocrine Neoplasms.

Clinical Impact of Molecular Tumor Board Inclusion on Treatment Outcomes in Neuroendocrine Neoplasms.

Journal: Neuroendocrinology

Published: January 24, 2026

Molecular Testing for Intrahepatic Cholangiocarcinoma: What, When, How?

Molecular Testing for Intrahepatic Cholangiocarcinoma: What, When, How?

Journal: Journal of gastrointestinal cancer

Published: December 14, 2025

The obese transplant organ recipient: experimental and clinical evidence for tailored immunosuppression.

The obese transplant organ recipient: experimental and clinical evidence for tailored immunosuppression.

Journal: Transplant international : official journal of the European Society for Organ Transplantation

Published: December 04, 2025

Moving Tumor-Agnostic Therapy to the Big Stage: Translational and Molecular Oncology Highlights from the ESMO Congress 2025.

Moving Tumor-Agnostic Therapy to the Big Stage: Translational and Molecular Oncology Highlights from the ESMO Congress 2025.

Journal: Oncology research and treatment

Published: December 01, 2025

Colibactin-producing E. coli promote carcinogenesis of gastroesophageal adenocarcinoma and simultaneously induce autophagy and differentiation.

Colibactin-producing E. coli promote carcinogenesis of gastroesophageal adenocarcinoma and simultaneously induce autophagy and differentiation.

Journal: bioRxiv : the preprint server for biology

Published: November 26, 2025

Increased reflux secondary bile acids are associated with changes to the microbiome and transcriptome in Barrett's esophagus.

Increased reflux secondary bile acids are associated with changes to the microbiome and transcriptome in Barrett's esophagus.

Journal: Gut microbes

Published: August 22, 2025

Gastrin for the treatment of acute graft-versus-host disease of the stomach.

Gastrin for the treatment of acute graft-versus-host disease of the stomach.

Journal: Blood

Published: August 01, 2025

Showing 1-12 of 137

Last Updated: 09/26/2026